Search Results

The NxStage Therapy System is indicated for treatment of renal failure or fluid overload using hemofiltration and/or ultrafiltration. The NxStage Cartridge Express is part of the NxStage Therapy System and is intended for use with the NxStage Cycler.

The NxStage Cartridge Express is an extracorporeal blood tubing set with preconnected high flux (permeability) hollow-fiber filter.

The provided text describes the NxStage Cartridge Express, a medical device, and its regulatory clearance. However, it does not contain the specific information requested regarding acceptance criteria and a study proving the device meets those criteria, as typically seen for AI/ML-based devices.

Here's why the requested information cannot be extracted from the provided text:

• Device Type: The NxStage Cartridge Express is described as an "extracorporeal blood tubing set with preconnected high flux (permeability) hollow-fiber filter," which is a physical medical device, not an AI/ML algorithm or system.
• Study Details: The document explicitly states "Clinical Data: Not applicable" and refers to "in vitro testing" to characterize performance and establish substantial equivalence to predicate devices. This type of testing for a physical device focuses on performance characteristics (e.g., filtration rates, biocompatibility), not on metrics like sensitivity, specificity, or reader improvement seen in AI/ML studies.
• Acceptance Criteria for AI/ML: The concepts of "acceptance criteria," "test set," "ground truth," "expert consensus," "MRMC studies," "standalone performance," and "training set" are primarily relevant to the validation of AI/ML algorithms, not to the in vitro testing of a physical hemifilter.

Therefore, I cannot provide the requested information in the format specified because it is not present in the provided document, as the device is not an AI/ML product.

The summary states:

• Summary of Non-clinical Test: "In vitro testing was conducted to characterize performance of the NxStage Hemofilter to provide a basis of comparison to the predicate devices. Results of in vitro studies have documented that the NxStage Cartridge Express is substantially equivalent to the predicate devices and is suitable for the intended use specified."
• Clinical Data: "Not applicable"

This indicates that the clearance was based on non-clinical, in-vitro testing demonstrating substantial equivalence to predicate devices, rather than a clinical study with detailed performance metrics against specific acceptance criteria for AI algorithms.

Ask a specific question about this device